{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:51Z","timestamp":1746417771968,"version":"3.40.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Atrial fibrillation (AF) is one of the most common arrhythmias, and is high relative to cardiovascular morbidity and mortality. AF-related complications and treatment costs bring about huge health burden, therefore the prevention recurrence of AF is imperative. \u201cUpstream therapy\u201d refers to the use of non-antiarrhythmic drugs (non-AADs) that modify the atrial substrate or target-specific mechanisms of AF to prevent the occurrence or recurrence of the arrhythmia. RAAS Blockers, aldosterone receptor antagonists and statins have an effect on preventing recurrence of atrial fibrillation. This protocol is designed for systematic review and network meta-analysis, which will assess comparative effects and safety of various non-antiarrhythmic drugs in preventing recurrence of atrial fibrillation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The Cochrane Library, MEDLINE, EMBASE, ClinicalTrials.gov will be searched from inception to Aug 31, 2020 to identify relevant studies. The Cochrane \u201cRisk of bias\u201d tool will be used to assess the methodological quality of eligible studies. The pair-wise meta-analysis will be performed by STATA 14.0 software. The network meta-analysis will be implemented in a Bayesian framework using Win BUGS 1.4.3 and the package \u201cgemtc\u201d V.0.8.1 of R-3.6.2 software. The network plots will be drawn using STATA 14.0 software. A comparison-adjusted funnel plot will be used to assess the publication bias using STATA 14.0 software. Quality of evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The results of this network meta-analysis will determine the preventive effect and rank ordering of these interventions for recurrence of AF. The report will follow the PRISMA checklist for network meta-analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This network meta-analysis will provide comprehensive evidence-based information in clinical practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Inplasy registration number:<\/jats:title>\n            <jats:p>INPLASY202090004.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024280","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:35:39Z","timestamp":1610584539000},"page":"e24280","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The effects of ACEI\/ARB, aldosterone receptor antagonists and statins on preventing recurrence of atrial fibrillation"],"prefix":"10.1097","volume":"100","author":[{"given":"Qiulei","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Cardiovascular, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbing","family":"Han","sequence":"additional","affiliation":[{"name":"Emergency Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqing","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhui","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehs469","article-title":"All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study","volume":"34","author":"Andersson","year":"2013","journal-title":"Eur Heart J"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"R3-20250504","first-page":"542","article-title":"Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management?","volume":"99","author":"Ball","year":"2013","journal-title":"Heart (British Cardiac Society)"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"448.e441","DOI":"10.1016\/j.amjmed.2005.10.057","article-title":"Quality of life in patients with atrial fibrillation: a systematic review","volume":"119","author":"Thrall","year":"2006","journal-title":"Am J Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ccl.2015.12.002","article-title":"The epidemiology of atrial fibrillation and stroke","volume":"34","author":"Pistoia","year":"2016","journal-title":"Cardiol Clin"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"J Cardiol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.chest.2017.03.048","article-title":"The global burden of atrial fibrillation and stroke: a systematic review of the clinical epidemiology of atrial fibrillation in Asia","volume":"152","author":"Bai","year":"2017","journal-title":"Chest"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ahj.2010.02.016","article-title":"Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial","volume":"159","author":"Disertori","year":"2010","journal-title":"Am Heart J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/europace\/eur194","article-title":"The cost of illness of atrial fibrillation: a systematic review of the recent literature","volume":"13","author":"Wolowacz","year":"2011","journal-title":"Europace"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0002-8703(03)00524-6","article-title":"Cost of care distribution in atrial fibrillation patients: the COCAF study","volume":"147","author":"Le Heuzey","year":"2004","journal-title":"Am Heart J"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12471-011-0175-4","article-title":"The burden of atrial fibrillation in the Netherlands","volume":"19","author":"Heemstra","year":"2011","journal-title":"Neth Heart J"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s12325-009-0066-x","article-title":"Cost of atrial fibrillation in United States managed care organizations","volume":"26","author":"Kim","year":"2009","journal-title":"Advances Therapy"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/eurheartj\/ehu001","article-title":"The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association","volume":"35","author":"Arbelo","year":"2014","journal-title":"Eur Heart J"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e004549","DOI":"10.1161\/JAHA.112.004549","article-title":"Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"2","author":"Ganesan","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","article-title":"Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"3","author":"Cappato","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1540-8167.2009.01493.x","article-title":"Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern?","volume":"20","author":"Dagres","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jce.12608","article-title":"Silent cerebral events\/lesions related to atrial fibrillation ablation: a clinical review","volume":"26","author":"Deneke","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/CIRCEP.113.000768","article-title":"Complications of catheter ablation of atrial fibrillation: a systematic review","volume":"6","author":"Gupta","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/europace\/eur023","article-title":"Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention","volume":"13","author":"Savelieva","year":"2011","journal-title":"Europace"},{"key":"R22-20250504","first-page":"ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0735-1097(00)00611-2","article-title":"Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation","volume":"35","author":"Goette","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/14779072.2017.1299005","article-title":"Molecular mechanisms of atrial fibrosis: implications for the clinic","volume":"15","author":"Thanigaimani","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/eurheartj\/ehr266","article-title":"Aldosterone promotes atrial fibrillation","volume":"33","author":"Reil","year":"2012","journal-title":"Eur Heart J"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1540-8159.2009.02673.x","article-title":"A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation","volume":"33","author":"Wozakowska-Kaplon","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1089\/ars.2013.5542","article-title":"Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins","volume":"20","author":"Pinho-Gomes","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000145163.56529.D1","article-title":"Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs","volume":"110","author":"Shiroshita-Takeshita","year":"2004","journal-title":"Circulation"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cardiores.2007.01.002","article-title":"Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure","volume":"74","author":"Shiroshita-Takeshita","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/clpt.2010.123","article-title":"The role of renin-angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"88","author":"Zhang","year":"2010","journal-title":"Clin Pharmacol Therapeutics"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","article-title":"Aldosterone pathway blockade to prevent atrial fibrillation: a systematic review and meta-analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int J Cardiol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2261-12-107","article-title":"Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis","volume":"12","author":"Loffredo","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"R33-20250504","first-page":"g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ (Clinical research ed)"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019\u200aAHA\/ACC\/HRS Focused Update of the 2014\u200aAHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration with the Society of Thoracic Surgeons","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/eb-2014-101900","article-title":"Addressing missing outcome data in meta-analysis","volume":"17","author":"Mavridis","year":"2014","journal-title":"Evid Based Ment Health"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet (London, England)"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PloS One"},{"key":"R43-20250504","first-page":"g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ (Clinical research ed)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:25:39Z","timestamp":1746339939000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024280"}},"subtitle":["A protocol for systematic review and network meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024280","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"2020-12-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}